YD Bio (YDESW) Receivables (2024 - 2026)

YD Bio (YDESW) has reported Receivables for 3 consecutive years, with $267722.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 60.25% year-over-year to $267722.0 in Q2 2026; TTM through Jun 2026 was $267722.0, a 60.25% increase from a year earlier, with the FY2025 full-year figure at $465615.0, up 336.93% from the prior year.
• Receivables was $267722.0 for Q2 2026 at YD Bio, down from $465615.0 in the prior quarter.
• Over five years, Receivables peaked at $465615.0 in Q4 2025 and troughed at $103509.0 in Q4 2024.
• A 3-year average of $250979.0 and a median of $217396.0 in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 349.83% in 2025 and surged 60.25% in 2026, its largest moves.
• Over 3 years, Receivables stood at $103509.0 in 2024, then soared by 349.83% to $465615.0 in 2025, then slumped by 42.5% to $267722.0 in 2026.
• The last three Receivables figures came in at $267722.0 (Q2 2026), $465615.0 (Q4 2025), and $167070.0 (Q2 2025), per Business Quant data.